Absorption of paroxetine under various dietary conditions and following antacid intake
1989; Wiley; Volume: 80; Issue: S350 Linguagem: Inglês
10.1111/j.1600-0447.1989.tb07185.x
ISSN1600-0447
AutoresW. H. Greb, Martin A. Brett, G. Büscher, H.‐D. Dierdorf, H. Schrader, David S. Wolf, G. Mellows, Barry D. Zussman,
Tópico(s)Treatment of Major Depression
ResumoActa Psychiatrica ScandinavicaVolume 80, Issue S350 p. 99-101 Absorption of paroxetine under various dietary conditions and following antacid intake W. H. Greb, W. H. Greb Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorM. A. Brett, M. A. Brett Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorG. Buscher, G. Buscher Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorH.-D. Dierdorf, H.-D. Dierdorf Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorH. W. von Schrader, H. W. von Schrader Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorD. Wolf, D. Wolf Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorG. Mellows, G. Mellows *Beecham Pharmaceuticals Research Division, Medicinal Research Centre, Harlow, Essex, United KingdomSearch for more papers by this authorB. D. Zussman, B. D. Zussman *Beecham Pharmaceuticals Research Division, Medicinal Research Centre, Harlow, Essex, United KingdomSearch for more papers by this author W. H. Greb, W. H. Greb Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorM. A. Brett, M. A. Brett Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorG. Buscher, G. Buscher Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorH.-D. Dierdorf, H.-D. Dierdorf Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorH. W. von Schrader, H. W. von Schrader Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorD. Wolf, D. Wolf Beecham-Wülfing Clinical Pharmacology Research Institute, Neuss, Federal Republic of GermanySearch for more papers by this authorG. Mellows, G. Mellows *Beecham Pharmaceuticals Research Division, Medicinal Research Centre, Harlow, Essex, United KingdomSearch for more papers by this authorB. D. Zussman, B. D. Zussman *Beecham Pharmaceuticals Research Division, Medicinal Research Centre, Harlow, Essex, United KingdomSearch for more papers by this author First published: June 1989 https://doi.org/10.1111/j.1600-0447.1989.tb07185.xCitations: 13AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume80, IssueS350June 1989Pages 99-101 RelatedInformation
Referência(s)